06Jun

If you’ve never worked with a recruiter, you might have some questions or concerns about the process. At Green Key Resources, our recruiters go above and beyond to provide a smooth and reputable experience for their candidates. To eliminate any confusion, we’ve answered a list of commonly asked questions, which we hope will kickstart your journey working with a recruiter and landing your perfect job! 

Do I need to pay to work with a recruiter? 

Nope! Recruiters are paid by the clients they recruit for, not by the candidate. You should never be paying a recruiter to use their services. 

How will a recruiter help me get a job? 

Recruiters generally have access to several job openings within a specific skillset. Often, they even recruit for open roles that are not available online, allowing you opportunities you otherwise might not have known about.  

What is the benefit of working with a recruiter? 

A good recruiter is a market expert. With perspective on market rates, recruiters let you know what people like yourself are being paid, what specific companies are willing to pay, and the other benefits associated with an offer. This might include bonuses, stock options, 401ks, health benefits, etc.

Recruiters also act as “resume writing experts,” who genuinely understand what companies and hiring managers are looking for on a resume. Not only are they capable of helping candidates edit and tailor their resumes accordingly, but they also assist in preparing for interviews. And on top of that, they are experienced negotiators, as it’s in their best interest to help you get the best offer possible.

How does the hiring process work with a recruiter? 

The hiring process with a recruiter is very simple. Recruiters are here to make everything easier for you, from the initial contact when you get to know each other, until you ideally accept a job offer.  

In between these events, recruiters will provide opportunities they believe would interest you, determine if you’d like to apply, and send your application to their client. From there, they will receive feedback from the company, which they will relay to you, and schedule an interview if they are interested. Should they want to hire you, your recruiter will present the job offer and aid in negotiation of salary.  

What happens if I don’t find a job working with a recruiter? 

Not to worry! If you don’t initially find a job working with a recruiter, they will continue to search for jobs that best match your interest and experience.

What is the advantage of working with a recruiter at Green Key? 

When working with a recruiter at Green Key Resources, you are getting the best of the best!  Green Key recruiters go above and beyond to develop relationships with folks that go beyond the scope of simply recruiting. While some recruiting firms look at people and candidates as a transaction to obtain commission, recruiters at Green Key see people for who they truly are – people. 

Jun 6, 2023

Drug Industry Invests $1 Billion For Antibiotic Development

Before the discovery of antibiotics, tuberculosis was the second most common cause of death in the US. Today, thanks to antibiotics, the few who contract the disease rarely die.

But as TB and other once-easily cured diseases grow increasingly antibiotic resistant, the very real fear is that medicine may run out of treatment options, leading to epidemics dwarfing COVID-19.

To head-off that kind of future, two dozen pharmaceutical firms have invested nearly $1 billion creating the AMR Action Fund with the goal of developing 2-4 new antibiotics by 2030.

AMR – antimicrobial resistance – arises when infectious disease pathogens become resistant to existing medicines. Tuberculosis is one of them, as are several others including the much publicized MRSA.

“AMR has the potential to render diseases that are relatively easy to treat today virtually incurable,” said Dr. Paul Stoffels, vice chairman of the executive committee and chief scientific officer, Johnson & Johnson.

“Left unchecked, AMR could significantly eclipse the global health challenge that the world is facing currently with COVID-19,” he said in a statement announcing the launch of the AMR Action Fund.

The initial funding pledges from the bioscience and drug firms – including $100 million pledged each by Johnson & Johnson and Pfizer – will be supplemented by non-industry partners, the Fund says on its website.

Explaining that “drug resistant bacteria are developing faster than new antibiotics can reach the market,” the Fund says there are few antibiotics in clinical development to meet current and anticipated needs. The reason is that the market for antibiotics “doesn’t support the level of investment needed to maintain a robust antibiotic pipeline.”

The website goes on to explain that smaller biotech firms have trouble financing trials of the antibiotics they do develop. Some that have developed new antibiotics “have declared bankruptcy or exited this space,” cautions the Fund, “Due to the lack of commercial sustainability, resulting in the loss of valuable expertise and resources.”

To achieve its goal of bringing to market the new antibiotics in a decade, the Fund said it “will invest in smaller biotech companies focused on developing new antibiotics that address the highest priority public health needs.”

Specifically, the AMR Action Fund will:

  1. “Invest based on the WHO/CDC priority lists of pathogens, with the goal to address major unmet needs and maximize public health impact.
  2. “Prioritize novel antibacterial treatments, as recognized by leading public health agencies, with significant and differentiated clinical utility and that reduces patient mortality.
  3. “Invest across all stages of clinical development.”

[bdp_post_carousel]